VERAHealthcareMid-Cap
Vera Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Vera Therapeutics, Inc. (VERA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are VERA insiders buying or selling?
Vera Therapeutics, Inc. insiders reported 34 open-market buys ($115.3M) and 63 sells ($84.3M) across 97 Form 4 filings — a net buying position of $30.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 9, 2026)
Total Form 4 filings
97
SEC EDGAR
Insider filers
19
Insider buys (34)
$115.3M
Insider sells (63)
$84.3M
Insider sentiment
Net buyingNet insider flow of $30.9M in net buying.
Recent VERA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 46.3K | $42.30 | $2.0M |
| Jun 24, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 18.5K | $37.93 | $701.8K |
| May 13, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 18.5K | $36.74 | $679.7K |
| Apr 15, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 23.0K | $44.05 | $1.0M |
| Feb 26, 2026 | Robert Brenner | Chief Medical Officer | Sale | 2.2K | $41.98 | $90.3K |
| Feb 26, 2026 | Joseph R Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 3.1K | $41.98 | $130.9K |
| Feb 26, 2026 | Sean Grant | CHIEF FINANCIAL OFFICER | Sale | 4.9K | $41.98 | $207.8K |
| Feb 26, 2026 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 16.9K | $41.98 | $710.6K |
| Feb 26, 2026 | David Lee Johnson | Chief Operating Officer | Sale | 2.6K | $41.98 | $108.3K |
| Feb 26, 2026 | William D. Turner | Chief Regulatory Officer | Sale | 2.2K | $41.98 | $91.8K |
| Feb 26, 2026 | Laurence Matthew Skelton | Chief Commercial Officer | Sale | 1.6K | $41.98 | $66.4K |
| Dec 17, 2025 | William D. Turner | Chief Regulatory Officer | Sale | 10.0K | $50.08 | $500.8K |
| Dec 16, 2025 | Patrick G Enright | Director | Purchase | 5.9K | $42.50 | $250.0K |
| Dec 10, 2025 | William D. Turner | Chief Regulatory Officer | Sale | 10.0K | $45.31 | $453.1K |
| Dec 4, 2025 | William D. Turner | Chief Regulatory Officer | Sale | 10.0K | $40.00 | $400.0K |
| Nov 25, 2025 | Jason S Carter | Chief Legal Officer | Sale | 3.9K | $27.82 | $107.5K |
| Nov 14, 2025 | Joseph R Young | SVP, FINANCE, CHIEF ACCT OFFCR | Sale | 15.0K | $29.06 | $435.9K |
| Jun 26, 2025 | Patrick G Enright | Director | Purchase | 250.0K | $21.11 | $5.3M |
| Feb 27, 2025 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 19.7K | $27.78 | $546.9K |
| Jan 10, 2025 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 17.5K | $41.74 | $730.5K |
| Dec 20, 2024 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 17.5K | $43.07 | $753.7K |
| Dec 13, 2024 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 17.5K | $46.94 | $821.5K |
| Nov 27, 2024 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 19.4K | $47.98 | $929.6K |
| Nov 15, 2024 | Marshall Fordyce | PRESIDENT AND CEO | Sale | 30.6K | $49.50 | $1.5M |
| Oct 30, 2024 | Beth C Seidenberg | Director | Sale | 15.0K | $48.03 | $720.5K |
Showing the 25 most recent of 97 Form 4 filings for Vera Therapeutics, Inc..
Most active VERA insiders
- Marshall Fordyce25 filings
- Joanne Curley18 filings
- Beth C Seidenberg14 filings
- Joseph R Young6 filings
- Sean Grant6 filings
Ask anything about VERA insider activity
Use Trabud's AI agent to query Vera Therapeutics, Inc.'s Form 4 history in plain English — "Show me VERA CEO purchases this year" or compare it against any other ticker.
Open the AI agentVERA insider trading FAQ
Are Vera Therapeutics, Inc. insiders buying or selling?
Across 97 SEC Form 4 filings, Vera Therapeutics, Inc. (VERA) insiders reported 34 open-market purchases totaling $115.3M and 63 sales totaling $84.3M. That is a net buying position of $30.9M.
How many insiders trade VERA stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Vera Therapeutics, Inc.. The most recent filing was accepted on Jul 9, 2026.
Where does Trabud get VERA insider trading data?
All VERA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.